Neoleukin Therapeutics, Inc.
NLTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21 | -$22 | -$23 | -$54 |
| Dep. & Amort. | $1 | $1 | $1 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $4 | $7 |
| Change in WC | $0 | $0 | $0 | $5 |
| Other Non-Cash | -$3 | -$2 | -$3 | -$9 |
| Operating Cash Flow | -$20 | -$19 | -$21 | -$49 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$77 | -$60 | -$89 | -$107 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$99 |
| Other Inv. Act. | $100 | $68 | $45 | $72 |
| Investing Cash Flow | $22 | $7 | -$45 | -$134 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10 | $0 | $0 | $184 |
| Financing Cash Flow | $10 | $0 | $0 | $184 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $12 | -$12 | -$66 | $111 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59 | $71 | $137 | $26 |
| End Cash | $71 | $59 | $71 | $137 |
| Free Cash Flow | -$20 | -$20 | -$22 | -$50 |